VENN STRATEGIES, LLC

Lobbying for UCB, INC. · Biopharmaceutical company dealing in severe diseases in immunology and neurology.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Georgia · House · Senate · $60,000.00 income · posted Jul 18, 2025

Lobbying activity 2

Health Issues

Policies related to biopharmaceutical access and innovation.

Taxation/Internal Revenue Code

International tax, corporate tax rate, and research and development tax issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.